AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
50th orphan medicine receives positive opinion.(Regulatory Action and News)
European Union -- Efforts in combating rare diseases reached a new milestone this October, with the 50th positive opinion on an orphan medicine being adopted by the EMEA's Committee for Medicinal Products for Human Use (CHMP).
To date, a total of 569 medicines have been awarded orphan-designation status by the European Commission, based on recommendations of the EMEA's Committee for Orphan Medicinal Products (COMP).
Developed specifically for the diagnosis, treatment or prevention of rare diseases, these medicines …
-
- British Biotech's leukaemia drug gets orphan medicine status.(Brief Article)
-
Newspaper article from: M2 Europharma
April 9, 2002
700+ words
-
- Committee for Medicinal Products for Human use Apr 2009 plenary meeting...
-
News wire article from: Chemical Business Newsbase
April 30, 2009
700+ words
-
- Committee for Medicinal Products for Human use Dec 2008 plenary meeting...
-
News wire article from: Chemical Business Newsbase
January 7, 2009
700+ words
-
- Committee for Orphan Medicinal Products public summary of positive opinion...
-
News wire article from: Chemical Business Newsbase
January 6, 2009
700+ words
-
- Meeting highlights from the Committee for Medicinal Products for Human Use,...
-
News wire article from: Chemical Business Newsbase
July 24, 2009
700+ words
